Literature DB >> 835077

Intraneoplastic injection of CCNU for experimental brain tumor chemotherapy.

C H Tator.   

Abstract

Chemotherapy experiments were performed with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) in an experimental mouse brain tumor model. Cell suspensions of a transplantable mouse ependymoblastoma were injected intracerebrally by means of a stereotactic frame. CCNU was given either intraperitoneally or by direct intraneoplastic injection beginning the fifth day after tumor cell implantation. Intraneoplastic injection beginning the fifth day after tumor cell implantation. Intraneoplastic injections of drugs were made with the stereotactic frame. A single intraneoplastic injection of CCNU was found to be highly effective in increasing the median day of death and in yielding large numbers of long-term survivors. In some experiments CCNU injected into the neoplasm produced increased numbers of long-term survivors and less systemic toxicity than when injected intraperitoneally.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 835077

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  5 in total

1.  The intraneoplastic chemotherapy in a rat brain tumour model utilizing methotrexate-polymethylmethacrylate-pellets.

Authors:  B Rama; T Mandel; J Jansen; E Dingeldein; H D Mennel
Journal:  Acta Neurochir (Wien)       Date:  1987       Impact factor: 2.216

2.  Interstitial chemotherapy of experimental brain tumors: comparison of intratumoral injection versus polymeric controlled release.

Authors:  K G Buahin; H Brem
Journal:  J Neurooncol       Date:  1995-11       Impact factor: 4.130

Review 3.  Interstitial chemotherapy for brain tumors: review.

Authors:  T Tomita
Journal:  J Neurooncol       Date:  1991-02       Impact factor: 4.130

4.  Intracerebral chemotherapy in the 9L rat brain tumor model.

Authors:  B F Kimler; C Liu; R G Evans; R A Morantz
Journal:  J Neurooncol       Date:  1992-11       Impact factor: 4.130

5.  Brain tumor chemotherapy using a rat glioma model.

Authors:  M Tamura; H D Mennel; K J Zülch
Journal:  J Cancer Res Clin Oncol       Date:  1979-05-14       Impact factor: 4.553

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.